Vical Inc. (VICL) announced an exclusive, binding letter of intent with EIP Eczacibasi Ilac Pazarlama A.S. for sales and marketing of the company's Allovectin-7 immunotherapeutic product candidate in Turkey and the Turkish Republic of Northern Cyprus.
EIP has agreed to obtain the necessary regulatory approvals for the territory and to pay Vical upfront and milestone payments in addition to a specified transfer price in exchange for the rights to an exclusive license for the territory.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.